Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Beta-lactoglobulin
Therapeutic Area : Technology
Study Phase : Preclinical
Sponsor : Hovione
Deal Size : Undisclosed
Deal Type : Expanded Collaboration
Details : Under their collaboration, Hovione and Zerion will now upscale and develop commercial formulations of the beta-lactoglobulin or BLG using the Dispersome® platform and make Lacprodan products available for distribution by partners globally.
Brand Name : Undisclosed
Molecule Type : Large molecule
Upfront Cash : Undisclosed
August 23, 2022
Lead Product(s) : Beta-lactoglobulin
Therapeutic Area : Technology
Highest Development Status : Preclinical
Sponsor : Hovione
Deal Size : Undisclosed
Deal Type : Expanded Collaboration
LOOKING FOR A SUPPLIER?